RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > CDSCO Releases Draft Formula for Clinical Trial Injury Compensation

CDSCO Releases Draft Formula for Clinical Trial Injury Compensation

Posted 02 May 2014 | By Louise Zornoza

India's Central Drugs Standard Control Organization (CDSCO) has issued a call for comments on its new formula for determining compensation for patients injured in clinical trials.

According to the draft, Draft Formula to Determine the Quantum of Compensation in Case of Clinical Trial Related Injury (Other Than Death), in cases of Serious Adverse Events (SAE) other than death, the CDSCO will determine the cause of injury and decide the amount of compensation.

The regulator said it plans to take into consideration the reports of the clinical trial investigator, the trial sponsor and the Ethics Committee that approved the trial.

The deadline for submitting comments is 16 May 2014, after which the drafting committee convened by Shri R. K. Jain will prepare a final version drawing on the comments submitted.

Read all Breaking News from RegLink


© 2022 Regulatory Affairs Professionals Society.